Who Will Join Us? EU Regulators Seek Feedback On Proposed Clinical Trials Discussion Platform
Executive Summary
Regulators want to know who is interested in joining their planned multi-stakeholder platform for discussions on how to improve clinical trials in Europe. They are also seeking feedback on which topics should be prioritized for discussion.
You may also be interested in...
EU To Consult On Plans For Holistic Dialog On Clinical Trials
EU regulators will soon be inviting feedback on plans to establish a keenly awaited platform that would allow EU clinical trial stakeholders to undertake regular discussions on improving the research landscape.
EMA Report Highlights Parallel Regulatory/HTA Consultations Among Achievements
A report from the EMA summarizing the mid-term achievements of its Regulatory Science Strategy to 2025 covers health technology assessments and a range of other topics.
Upstaza: First Gene Therapy For Ultra-Rare Disorder AADC Deficiency Receives English Funding
The single-dose gene therapy for aromatic L-amino acid decarboxylase in children is to be made available on the National Health Service following a confidential commercial deal between NHS England and PTC Therapeutics.